Blockade of myeloid differentiation protein 2 prevents obesity-induced inflammation and nephropathy.
Ontology highlight
ABSTRACT: Obesity is a major and independent risk factor of kidney diseases. The pathogenic mechanisms of obesity-associated renal injury are recognized to at least involve a lipid-rich and pro-inflammatory state of the renal tissues, but specific mechanisms establishing causal relation remain unknown. Saturated fatty acids are elevated in obesity, and known to induce chronic inflammation in kidneys. Myeloid differentiation protein 2 (MD2) is an important protein in lipopolysaccharide-induced innate immunity response and inflammation. We suggested that obesity-associated renal injury is regulated by MD2 thereby driving an inflammatory renal injury. The used three mouse models for in vivo study: MD2 knockout mice (KO) maintained on high fat diet (HFD), wild-type mice on HFD plus L6H21, a specific MD2
SUBMITTER: Fang Q
PROVIDER: S-EPMC5706499 | biostudies-literature | 2017 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA